AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: ADCIRCA (United Therapeutics) (adcirca.com)
ADCIRCA.com is a high-substance, low-fluff pharmaceutical site that provides nearly maximum transparency regarding clinical trial outcomes and side effects. It avoids the typical industry trap of health-washing by pinning every marketing claim to a specific metric from a 16-week clinical study. The minimal BS score is only reflective of minor template repetition and the lack of direct peer-reviewed paper citations in the text.
Integrate direct citations or DOI links to the specific peer-reviewed clinical studies mentioned to provide a complete proof path for healthcare professionals. Reduce the verbatim repetition of the 33-meter walk distance statistic across the internal pages to improve Information Density. Update the schema to resolve the review count flags by either linking to actual patient testimonials or removing the review property from the JSON-LD. Add the specific FDA approval date and NDA number to the About Adcirca page to further ground the regulatory claims in technical fact.
The information density is exceptionally high for a patient-facing site, with the body substance ratio heavily weighted toward hard data. Specific metrics such as the 33 meters (108 feet) average increase in 6-minute walk distance (6MWD) and the 16-week trial duration are cited across multiple pages. While headings like Keep moving forward and Resources contain some thematic fluff, they are immediately anchored by specific nouns like tadalafil and PAH. The site does lose points for concept repetition, as the 33-meter statistic is restated verbatim at least four times across the crawled pages.
If your canonical, redirect, and final URL disagree, AI cannot determine which version to trust. Verify your Identity Stability for free and detect conflicts before they fragment your authority.
There is zero detectable semantic drift between the homepage signal and the sub-page substance. The homepage H1 promises a treatment to improve exercise ability, and the About ADCIRCA sub-page delivers the technical mechanism (PDE-5 inhibitor) and the clinical data justifying that claim. The messaging remains consistent across the About PAH and Cost Support pages, with no conflicting audience shifts or contradictory service descriptions. Even the patient assistance programs are clearly defined with eligibility criteria rather than vague promises of affordability.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
Trust theatre is minimal, though the data shows a review count of 1 on internal pages without a verified proof link, likely a schema implementation artifact. The site compensates by providing external proof paths to the FDA MedWatch program, the National Heart, Lung, and Blood Institute (NHLBI), and the Pulmonary Hypertension Association (PHA). Performance claims regarding clinical worsening and exercise improvement are backed by specific trial parameters, although direct DOI links to the peer-reviewed publications are absent from the body text. The trust theatre flag is triggered only by the technical schema discrepancy rather than deceptive marketing claims.
Proof density is high, with the ratio of verifiable metrics to vague assertions favoring the former. The site provides specific percentage breakdowns for patient populations (e.g., 61 percent idiopathic PAH, 23 percent connective tissue diseases). It also includes a detailed list of inactive ingredients and specific financial benefit caps ($800 monthly benefit), which serves as a primary BS-reducer. Verifiable evidence is woven into the primary narrative rather than being hidden in fine print.
To examine how structural entropy affects chunking and retrieval, review the Moz Semantic HTML audit. View the Moz Semantic HTML Audit for a complete example of heading logic, landmark integrity, and DOM depth diagnostics.
The site avoids most high-intensity industry clichés, though it does utilize standard pharma value prop cliches such as improve exercise ability and resources to support your treatment. The value proposition is highly unique because it is tied to a specific FDA-approved indication for tadalafil (ADCIRCA) rather than generic health-washing. Boilerplate sections like FAQs and Resources & Support are present but are populated with drug-specific data rather than generic template filler. The overall fingerprint is that of a highly regulated medical product rather than a commoditized service provider.
There are no significant authority gaps as the brand is explicitly linked to United Therapeutics in the schema and footer. The technical implementation of MedicalWebPage and Drug schema is robust, providing clear identifiers for the active ingredient (tadalafil) and the publisher. While individual doctors are not named, the reliance on institutional authority (FDA, NIH) is appropriate and standard for this category. There is no evidence of expert claims that lack a digital footprint; the authority is the clinical trial data itself.
The performance claims are exceptionally grounded, contrasting the marketing tone of Keep moving forward with the clinical reality of 33-meter walk distance improvements. Unlike sites that claim breakthrough results, this site defines clinical worsening specifically as death, lung transplantation, or hospitalization. There is a strong connection between the benefit claimed (improved exercise ability) and the metric provided (6MWD results). The site successfully avoids the disconnect common in pharma where lifestyle imagery masks modest clinical efficacy.
Medical Devices, Pharma & Biotech BS: ADCIRCA (United Therapeutics) (adcirca.com)
The site content perfectly aligns with the Pharmaceutical and Biotech industry, focusing heavily on a specific molecule (tadalafil) for a specific therapeutic area (PAH). It strictly adheres to regulatory communication standards by including required safety information, mechanism of action, and clinical trial results.
If your entity graph is unstable, every other part of the framework inherits that instability. Study the Structured Data Framework Guide and see why schema is not markup — it is the machine readable definition of your domain.
“The score of 11 is driven by high Information Density and Semantic Coherence. Points were only deducted for minor repetition of clinical stats (Pillar 1) and technical schema flags for unverified review counts on sub-pages (Pillar 3). The Identity and Coherence scores were 0, reflecting a site that is technically and substantively honest.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 26, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at ADCIRCA (United Therapeutics) to view the most current version of their content and see directly what the company offers.